Back
DexCom Quote, Financials, Valuation and Earnings
Sponsored
DXCM
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
DXCM
DexCom
Last Price:
70.04
Seasonality Move:
-1.82%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerDexCom Price Quote
$70.04
+0.53 (+0.76%)
(Updated: September 16, 2024 at 4:25 PM ET)
DexCom Key Stats
Sell
46
DexCom (DXCM)
is a Sell
Day range:
$68.14 - $69.90
52-week range:
$62.34 - $142.00
Dividend yield:
0%
P/E ratio:
53.47
P/S ratio:
7.41
P/B ratio:
11.44%
Volume:
2.6M
Avg. volume:
4.8M
1-year change:
-33.94%
Market cap:
$27.9B
Revenue:
$3.6B
EPS:
$1.62
How Much Does DexCom Make?
Is DexCom Growing As A Company?
DexCom Stock Price Performance
What Is DexCom 52-Week High & Low?
DexCom Price To Free Cash Flow
-
Is DexCom Stock Overvalued?
DexCom is trading at a price to free cash flow ratio of 43.80 -
Is DexCom Stock Undervalued?
DexCom EV to Free Cash Flow ratio is 40.83 -
What Is DexCom’s Price Earnings Growth Ratio?
DXCM PEG ratio is 0.49 -
Is DexCom Trading At A Premium To Earnings?
DexCom EV to EBIT ratio is 32.89
Is It Risky To Buy DexCom?
Is DexCom Cash Flow Positive?
DexCom Return On Invested Capital
DexCom Earnings Date & Stock Price
-
What Is DexCom's Stock Price Today?
A single share of DXCM can be purchased today for 69.51 -
What Is DexCom’s Stock Symbol?
DexCom trades on the nasdaq under the ticker symbol: DXCM -
When Is DexCom’s Next Earnings Date?
The next quarterly earnings date for DexCom is scheduled on October 25, 2024 -
When Is DXCM's next ex-dividend date?
DexCom's next ex-dividend date is May 1, 2020 -
How To Buy DexCom Stock?
You can buy DexCom shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
DexCom Competitors
DexCom Dividend Yield
DexCom Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 25% | 11.36% |
Revenue: | 15.27% | -3.15% |
Analyst Recommendations
Buy Recommendations: | 15 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 95.87 |
Upside from Last Price: | 37.92% |